Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $284,333 | 9 | 98.8% |
| Travel and Lodging | $2,638 | 6 | 0.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $700.00 | 1 | 0.2% |
| Food and Beverage | $120.20 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SERVIER PHARMACEUTICALS LLC | $202,368 | 5 | $0 (2022) |
| Servier BioInnovation | $81,965 | 4 | $0 (2023) |
| Exelixis Inc. | $2,727 | 9 | $0 (2019) |
| PFIZER INC. | $700.00 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $30.85 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $53,970 | 3 | Servier BioInnovation ($53,970) |
| 2022 | $230,363 | 6 | SERVIER PHARMACEUTICALS LLC ($202,368) |
| 2019 | $2,727 | 9 | Exelixis Inc. ($2,727) |
| 2017 | $730.85 | 2 | PFIZER INC. ($700.00) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/06/2023 | Servier BioInnovation | — | Consulting Fee | Cash or cash equivalent | $11,460.00 | General |
| 02/06/2023 | Servier BioInnovation | — | Consulting Fee | Cash or cash equivalent | $7,215.00 | General |
| 01/04/2023 | Servier BioInnovation | — | Consulting Fee | Cash or cash equivalent | $35,295.00 | General |
| 12/02/2022 | SERVIER PHARMACEUTICALS LLC | — | Consulting Fee | Cash or cash equivalent | $31,395.00 | General |
| 11/07/2022 | SERVIER PHARMACEUTICALS LLC | — | Consulting Fee | Cash or cash equivalent | $33,930.00 | General |
| 10/04/2022 | SERVIER PHARMACEUTICALS LLC | — | Consulting Fee | Cash or cash equivalent | $72,421.50 | General |
| 09/19/2022 | Servier BioInnovation | — | Consulting Fee | Cash or cash equivalent | $27,994.99 | General |
| 09/05/2022 | SERVIER PHARMACEUTICALS LLC | — | Consulting Fee | Cash or cash equivalent | $42,001.75 | General |
| 07/25/2022 | SERVIER PHARMACEUTICALS LLC | — | Consulting Fee | Cash or cash equivalent | $22,620.00 | General |
| 09/06/2019 | Exelixis Inc. | Cabometyx (Drug) | Travel and Lodging | Cash or cash equivalent | $259.53 | General |
| Category: Oncology | ||||||
| 09/06/2019 | Exelixis Inc. | Cabometyx (Drug) | Travel and Lodging | Cash or cash equivalent | $58.32 | General |
| Category: Oncology | ||||||
| 09/06/2019 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | Cash or cash equivalent | $57.53 | General |
| Category: Oncology | ||||||
| 09/06/2019 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | Cash or cash equivalent | $18.33 | General |
| Category: Oncology | ||||||
| 08/21/2019 | Exelixis Inc. | — | Travel and Lodging | In-kind items and services | $807.61 | General |
| 08/13/2019 | Exelixis Inc. | Cabometyx (Drug) | Travel and Lodging | In-kind items and services | $807.61 | General |
| Category: Oncology | ||||||
| 08/13/2019 | Exelixis Inc. | Cabometyx (Drug) | Travel and Lodging | In-kind items and services | $212.10 | General |
| Category: Oncology | ||||||
| 08/13/2019 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Oncology | ||||||
| 04/22/2019 | Exelixis Inc. | — | Travel and Lodging | In-kind items and services | $492.59 | General |
| 11/19/2017 | Novartis Pharmaceuticals Corporation | RYDAPT (Drug) | Food and Beverage | In-kind items and services | $30.85 | General |
| Category: HEMATOLOGY | ||||||
| 03/23/2017 | PFIZER INC. | BOSULIF (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $700.00 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
About Dr. Ewa Matczak, MD
Dr. Ewa Matczak, MD is a Hematology & Oncology healthcare provider based in Forest Hills, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2009. The National Provider Identifier (NPI) number assigned to this provider is 1346478468.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ewa Matczak, MD has received a total of $287,791 in payments from pharmaceutical and medical device companies, with $53,970 received in 2023. These payments were reported across 20 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($284,333).
Practice Information
- Specialty Hematology & Oncology
- Location Forest Hills, NY
- Active Since 06/26/2009
- Last Updated 03/07/2023
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1346478468
Products in Payments
- Cabometyx (Drug) $1,427
- BOSULIF (Drug) $700.00
- RYDAPT (Drug) $30.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Forest Hills
Dr. Vladimir Gotlieb, Md, MD
Hematology & Oncology — Payments: $85,447
Jane Daly, Md, MD
Hematology & Oncology — Payments: $8,156
Dr. Dhvani Thakker, M.d, M.D
Hematology & Oncology — Payments: $2,416
David Askin, D.o, D.O
Hematology & Oncology — Payments: $1,249
George Spanos, Md, MD
Hematology & Oncology — Payments: $378.13
Shanta Bajaj, Md, MD
Hematology & Oncology — Payments: $302.61